*****This thread is setup mainly to gain information
relating to Mediwatch in a quick and easy way and IS IN NO WAY A
RECOMMENDATION TO BUY!********


Mediwatch-A Synopsis:
Mediwatch was established in 1996 and has developed a range of specialist
medical equipment for the diagnosis of urological disorders.The group joined the
AIM in 2000 through a reverse into Prostcare plc,which at the time was valued at
8m.While the vast majority of sales were generated in the UK,there was a
substantial indirect export business involving a number of agents,supplying into
Europe,North America,Australasia and Asia,notably Japan.
Group revenues are set to increase rapidly following the acquisition of the former
Medtronic Urodynamis Division,which has introduced a fundamental presence in
North America.The deal was in 2006 with the sales division building from 2007.
With the inclusion of the Medtronic systems now owned by Mediwatch they now
can offer a 'One Stop Shop' for the diagnosis of various urology disorders with the
benefit of Mediwatch systems having the ability to electronically send data from the
various tests to a central data base!Oh and plus the added bonus of PSAwatch and
now PCA3plus!

More than 30 million PSA tests are performed annually in the USA alone!

CHARTS

FUTURE EVENTS AND LATEST
NEWS

Just for the record and to even things up,this is Treblewide's view (near end
of 2008):

"in short 3p by chrimbo and a real chance if they do not get rid of management they
will go into receivership.....when they bough the MDT business I said at the time it
must have been a bag of shite as they only paid buttons for it.......looks like that was
fairly correct......i feel sorry for shareholders"

Treblewide has been filtered from my eyes for his abuse,lies and general behavior but
it's a free country (I think) so do as you see fit.


It started with:

Treblewide - 05 Jun 2007 15:49 - 33 of 1747
still short

Treblewide - 18 Jun 2007 00:24 - 69 of 1747
interesting stuff from that article...very few men die from prosate cancer and it is not an agressive disease....treatment can be worse than the disease.......kind of suggests their whole business model is based on sand to me.......but hey who wants a balanced view.

Treblewide - 18 Jun 2007 00:31 - 76 of 1754
exercise and sex may cause a raised PSA...so you guys may have stumbled on a test for fit shaggers :-)

I am gonna name Me-Di-Watch

Gonna-go-bust-soon-iwatch

Treblewide - 18 Jun 2007 10:59 - 85 of 1754
minder...i do not make light of prosate cancer....show me one post where I do...i make fun out of this company yes but not the disease so wind yer neck in pal.

show me any trace of a profit and i will maybe change my mind

Treblewide - 18 Jun 2007 15:54 - 97 of 1754
minder made a small loss yes which I have more than made up for shorting it........and i guess your average holding is 3p.....aye right.

Aalso I closed out my short at 8p for a loss of the spread if memory serves me correctly.

currently short from 13.25....i thank you and goodnight

Treblewide - 23 Jul 2007 12:36 - 154 of 1747
more of the same......thank god i still do not own shares in this lot...will they ever
make a penny profit....looks doubtful......cannot even manage a small supply chain.


ect ect ect

with the last few posts:

Treblewide - 30 Mar 2009 09:16 - 1704 of 1754
you are a lunatic mick.....words fail me.

and ps i only post under treblewide on any financial web site....i know you cannot say the same......you have been calling this as a buy and nothing but a buy for about 7 years...it says it all really about your stock picking ability

i notice the downtrend ins now establishing itself....re-visit of the lows again by the looks of things

Treblewide - 30 Mar 2009 22:41 - 1712 of 1754
mick no i dont know what each product does...i dont think that is important...the numbers tell everything and even though you must spend hours on web sites searching for stuff that is not even related to MDW you fail to grasp the basics...they consistently lost money and now seem to be making some...my call to 3p was correct and i think if they had not got their shit together they could have gone under

i was not interested in them as a long play while they were loosing money depsite whatever rubbish you posted regarding piss sticks or whatever you bang on about.

and yes it was poor trading..having an avergae of 12 and averaging down to 6-7p while they were at 3p....is terrible trading...that cannot even be debated...the very fact you know so much about the products means you have fallen in love with this company......which is very dangerous when investing....

the numbers are the important things...i was right on 3p, the company is posting slightly better figures but we are in a bear market which has not bottomed yet so the price will fall further

you are a 1 trick pony that posts irrelevant links...dont bother to respond i can be bothered getting into a debate with you.....away and cut and paste some more flags

toodlepip

**************************************************************

I have been chased from here and now ADVFN,has the boy got a problem?

treblewide - 3 Aug'09 - 14:46 - 22345 of 22412


post 22342 is classic.....so mick advfn is not a good source when the consensus is sell?

begs the question why you spend so much time polluting it with your bull tripe?

question....so MDW share price has gone up, it has gone down etc etc...during all of that time has mick ever been able to find any subjectivity in his posting ie has he ever critisised anything?

i really think he may be getting paid by MDW...the whole thing is very bizzare.

mick i notice you referred to your threads as "promotion of Mediwatch"

can you confirm if you are getting financially rewarded by the company for this?

treblewide - 3 Aug'09 - 23:55 - 22371 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....



treblewide - 4 Aug'09 - 00:19 - 22373 of 22412


664k overdrawn....takes a long time to pay back at 39k profit every 6 months.

drawn down overdraft has increased by 170k and they paid 33k to service that overdraft and made 39k profit...as i keep saying my local fish and chip shop make more money than this lot.

margins have been squeezed...psa watch now off the agenda in terms of updates....not 1 single reason to buy and yet you lot think this share price will go up??.....am mystified why it would increase? genuinely why is this comapny under valued?? i cannot see it and dont bang on about fairfax saying they are going to make x amount...they have never been near to getting it right

if i were a holder i would be selling now at 6p if i could and buying back in the 2-3p range which the chart is saying is now a certainty....i expecta full year loss

i told you all to sell at 14p and at 11p (it is all there in black and white) and that it was going to 3 pence..i got abuse mick called me an idiot and suggested it was going to 50p......still a sell and my short (which was posted in real time over the road) is nicely in profit.

toodle pip...will log back in when it gets to 3p....

treblewide - 4 Aug'09 - 10:49 - 22379 of 22412


still time to get out at 6p.....dont understand why you would not sell at 6p when they are obviously going to half in value...if you are a long term mdw bull you can buy twice as many shares at 3p and maybe possibly one day see a profit on your holding?



treblewide - 4 Aug'09 - 12:44 - 22381 of 22412


last chance to sell at 6p for your shares folks


treblewide - 4 Aug'09 - 14:48 - 22387 of 22412


so question...is psawatch is so great...why has there been no huge surge in revenue figures from UK and Europe on the back of it being sold?

the whole reason a lot of you hold this is psawatch...it has not made them any money in Europe which could be argued when taken as a whole is not much smaller than the USA.....this company is not going to change overnight with US approval...at bets it would be a selling opportunity for long term holders

i really think a lot of you have to ignore some of the nonsense ramping going on here...the company is draining cash and there margins are reducing (despite this wonder PSA machine they have for sale)

i really think the future looks bleak for mediwatch...if someone can put in concise terminology why MDW is a buy i am all ears....dont point me at fairfax report...they are a bunch of clowns as well...that interim report is shocking and i mean really poor.

costs out of control...margins squeezed, cash running out...no real revenue growth, does this sound like a growth company to you?

sell at 6p


treblewide - 4 Aug'09 - 15:50 - 22391 of 22412


god i have heard it all now...mick can you counter my points about declining margins and cash issues without nonsense posts about peopel having insider information...what a crock and what a clown.

so just so i have this straight in my head...when you put in effort to ramp these shares it is all great and you expect cuddles? (and if anyone disagrees you throw your toys out the pram liek an old woman)

when i put up a few posts to explain why i am short it is an organised attempt to get the share price down because i have insider inforamtion from the US?

were you the Iraqi information minister in a previous role? lol


treblewide - 5 Aug'09 - 19:24 - 22409 of 22412


lol.....shares getting sold today at 5.75.....next stop 3p...

treblewide - 4 Aug'09 - 12:44 - 22381 of 22408 edit


last chance to sell at 6p for your shares folks




treblewide - 5 Aug'09 - 19:29 - 22410 of 22412


i wonder what thier overdraft is limited to....1M?

if so they have 12 months of life left at current perfomance...how many of you hlders have considered the chances of them going bust?....i would not rule it out...would love to know how much further the banks will let them go into debt before they pull the plug

treblewide - 5 Aug'09 - 19:37 - 22411 of 22412


seriously if i were a holder i would look at the interims and ask how much longer can they go on burning cash.......and with all the averaging down the bulls have done over the years i bet some are more exposed than they should be....good luck...think you might need it




ANYWAY

http://mediwatch.blogspot.com/

Just to clarify regarding reports of a new test for PC using circulating tumour cells to measure the disease status.This has of course got nothing to do with or effects MDW's PSAwatch in any way!

The test is purely for advanced cases of PC in assessing the effectiveness of chemotherapy.The Prostate Cancer Charity explain it better than me and issued today:

The Prostate Cancer Charity comments on a study exploring the role of circulating tumour cells

Banjo, You are working hard on this share.

Evening Fred,

Just looking after my investment but I must admit to enjoying all the research that goes with it.I do buy and sell shares in other stocks by the way,although not on a frequent basis.

Can't find the link for this and forgot where I got it from:

Expansion into urology services

Another growth driver, apart from gaining market share via its one-stop shop offering in urology diagnostics and from potential growth in global PSAwatch sales, will be Mediwatchs expansion into urology services (estimated 330m market size). This will be a lower price point offering compared to solely selling equipment- this will provide balance to the companys total offering and could become more popular in a weak global economy. These services should grow long term as Governments and medical insurers move towards preventative care.

The company has teamed up with Bostwick Laboratories (provides global urology
pathology services to private offices and hospitals) to provide a whole range of DNA tests and pathology services to urologists and provide a mobile screening clinics service(see some Bostwicks products on page 6). The latter service will involve supplying urodynamics equipment and tests, bladder screening and PSA screening to private clinics and nursing homes.
For pathology services,the company will look to do partnership deals with a pool of pathologists and then look to offer a greater range of tests at competitive prices to urologists.For private clinics, the company will look to supply equipment in to the clinics and then hire a nurse once the contract with the doctor has been signed. The nurse will get paid by Mediwatch per test carried out.For nursing homes or Assisted Living Facilities, a large market has been identified in the USA that requires urological diagnostics. Recent legislation outlines how patients should be cared for, particularly those suffering with incontinence. Mediwatch has hired a specialist to design a programme that will break the company into this lucrative market during 2009.

The company will strive to keep the costs of starting up these services low;

(1) The company has researched these markets in depth.
(2) The expansion will be done cautiously- in pathology, the initial focus will be on 2 regions of the UK whilst services for US mobile clinics will be introduced firstly in to Florida (where there are 1,100 nursing homes).
(3) For mobile clinics, the main expense is the cost of the manufactured goods
(equipment and readers), which is estimated to be only 1,500/ nurse.

The Anniversary Colorectal Disease Symposium Florida (USA) Feb 12th - 14th 2009 ended today and the next event MDW are exhibiting/attending is:

February 25 28, 2009 Las Vegas, Nevada

Intermittent Catheter Market to Surpass 40% CAGR Between 2008 and 2012
New Medicare Reimbursement will have Significant Impact on the Intermittent Catheter Market, according to Millennium Research Group


WALTHAM, Mass., Feb. 19 /PRNewswire/ -- Millennium Research Group (MRG) has updated its US Markets for Urological Devices 2008 report to reflect momentous shifts in the US intermittent catheter market. Due mainly to a favorable upgrade in Medicare reimbursement, the US intermittent catheter market, comprising reusable straight strips, disposable gel-coated strips and trays, and disposable hydrophilic strips, will achieve a compound annual growth rate (CAGR) above 40% between 2008 and 2012.


Effective April 1, 2008, the number of intermittent catheters covered by Medicare increased from four per month to a maximum of 200 catheters per month, promoting single-use catheterization. One of the largest influences driving this change was the November 2007 recommendation from the Department of Veterans Affairs (VA) that its clinicians follow all manufacturer instructions for catheter use, ensuring that catheters classified as single use by manufacturers and the FDA are not reused. In order to provide consistency among government organizations, Medicare reimbursement was changed shortly following recommendations from the Department of VA.


"Also important was that on October 1, 2008, Medicare withdrew reimbursement to hospitals for treating certain conditions that were not present on admission, including catheter-associated urinary tract infections," says Lexie Code, Manager of the Endoscopy division at MRG. "Because intermittent strips are inserted only when the need to drain urine arises and therefore result in fewer infections, hospitals have an additional incentive to adopt these products, further driving market expansion."


MRG's US Markets for Urological Devices 2009 report provides a detailed qualitative and quantitative analysis of the new reimbursement, as well as numerous other urological device markets in the areas of incontinence, prostate cancer, stone management, benign prostatic hyperplasia (BPH), and erectile dysfunction (ED). Coverage of key industry competitors includes American Medical Systems, C.R. Bard, Caldera Medical, Cook Urological, Coloplast, Lumenis, Olympus, Richard Wolf, and many more.

http://www.rehabpub.com/press_release.asp?id=10223071

MDW-Disposables

MDW-Urodynamics Accessories Catalogue

This is quite interesting as in the name,the address is MDW's HQ.

MEDIWATCH DIAGNOSTIC CLINICS LTD

http://www.192.com/local/CV21/CLINIC/MEDIWATCH_DIAGNOSTIC_CLINICS_LTD/X983B6697C36643A2A1C49F79089384CE

Spring is on it's way,wonder if it will wake up? I'll have to look into all this another time as there might be nothing to it all.

Taken from the 2005 Annual Report,page 22:

At 30 April 2005 the Company held directly the whole of the allotted share capital of the following subsidiary undertakings undertakings,all incorporated in England and W Wales:

Mediwatch UK Limited engaged in the development of primary care urology products and services.

Mediwatch Biomedical Limited engaged in the development of medical equipment.

Mediwatch Diagnostic Clinics Limited dormant.

MDW 2005 Annual Report

I'll just lob this here and have a look tonight,I think someone from over the 'dark side' mentioned this a few weeks back:

http://www.do-business.net/CompanySelect/ukd.aspx?key=2d3fc5ae-807e-41e5-8390-d6402188de8b

The MDW Annual Report is now available via their website:

http://www.mediwatch.com/AnnualReport.php

Relating to post 1549 and from the 2008 Annual Report we now see an addition to the previous list with the 'Diagnostic Clinics' side still asleep:

At 31 October 2008 the Company held directly the whole of the allotted share capital of the following subsidiary undertakings, all incorporated in England and Wales:

Medi-Watch UK Limited engaged in the development of primary care urology products and services.

Mediwatch Biomedical Limited engaged in the development of medical equipment.

Mediwatch Diagnostic Clinics Limited dormant.

Mediwatch Pathology Limited engaged in the sale of pathology tests.

I'm not sure whether a National Screening Program using the PSA test will ever materialise in the UK, due to cost of follow ups and the fact that the PSA test is not a direct test for prostate cancer! MDW might have other ideas though! :-)

And just to reiterate what the PSA test does do-It is the only initial test used along with the DRE to indicate possible problems which may include prostate cancer! The earlier a PSA test is carried out the better and then repeated on a yearly basis if original result caused no concern.It's all about interpretation of results and rate of change over time basically.

Getting back to this post,the Norfolk & Waveney Prostate Cancer Support Group newsletter that started me off as in a national screening program being their aim and I can't fault them for trying but more interesting to me regarding PSAwatch and what I think is the key issue which is gaining public awareness along with the NHS/PCT's getting the data required to at least promote the test in a more positive light,is what they are also contributing to.

"The Trust and Kidderminster Prostate Cancer Support Group have between them held 68 similar events across the country since 2005.
In all 6788 men have had PSA tests,resulting in a find rate of cancers of about 3 percent."

"The aim of the sessions is to obtain data from 10,000 men.The results will be given to the NHS to help it to decide whether to introduce a national screening pogramme."

"In the meantime, we can give 200 men an opportunity to learn about prostate cancer, and have a free PSA test, and at the same time contribute data to an important national trial."

http://www.prostatesupport.org.uk/NewsletterJan09.pdf

Date: Monday, 23 February 2009

Mediwatch plc

Annual Report & Accounts


The 2008 Report & Accounts have been posted to shareholders and an on-line version can be found on the Company's website www.mediwatch.com.

The Annual General Meeting will be held at 11.00am on Thursday, 26 March 2009 at the offices of Grant Thornton UK LLP, 30 Finsbury Square, London, EC2P 2YU.

Patient calls for a screening test for prostate cancer for all men in Wales
Feb 23 2009 by Madeleine Brindley, Western Mail

A PROSTATE cancer patient is hoping to offer all men over 50 in Wales a PSA test in a bid to detect the disease.

Reg Williams, who founded the South Wales-based Prostate Screening Trust, is exploring the possibility of using a mobile PSA testing machine which can give a result in just 20 minutes.

He hopes to be able to offer the test throughout Wales in the absence of a national screening programme.

The new technology uses a finger-prick blood sample to test levels of the prostate specific antigen. Raised levels can be an indication of prostate cancer and other benign conditions.

http://www.walesonline.co.uk/news/wales-news/2009/02/23/patient-calls-for-a-screening-test-for-prostate-cancer-for-all-men-in-wales-91466-22985157/

Further links relating to the above:

Where are the activists? Where is the research?

Prostate Screening Trust

You and Yours - Transcript

Grand Slam signatures get mens health message across

Banjo, Have you got your life savings in this one?

Evening Fred,
Nooooooo

Experts advise a wait-and-see approach on treating low-grade prostate cancer
By STEPHANIE DESMON The Baltimore Sun

Published: Monday, February 23, 2009

""The knee-jerk reaction that everyone with prostate cancer needs curative intervention may not be the best approach," Carter said.

Leading prostate cancer experts agree that close monitoring of the disease - a process known in some circles as watchful waiting, in others as active surveillance - probably is the best course for a large number of men. But few long-term studies have been done to confirm that, because few men are willing to participate in research in which the cancer is left untreated."


"Thanks to PSA, many of the cancers being found are much smaller - and less dangerous - than those that had been discovered through physical exams. So the question has become: What should be done about them?

"That really is the big conundrum in prostate cancer, whom to treat," said Dr. Howard Parnes, chief of the prostate and urological research group at the National Cancer Institute in Bethesda. "Many more men die with prostate cancer than from prostate cancer."

In determining whether a patient is a candidate for active surveillance, Carter looks at PSA levels, whether a tumor is palpable during a physical exam and a score based on the microscopic appearance of cancer cells in prostate tissue, which gives an idea of a cancer's aggressiveness.

Carter cautions that he is "incredibly conservative" about whom he chooses for surveillance. He rarely includes men in their 50s because if he and his staff are wrong, the chances of harm are greater. Older men are more likely to have other diseases that are likely to claim them before the cancer does."

http://www.pressofatlanticcity.com/114/story/410135.html

Productivity Costs Of Cancer Mortality In The United States: 2000-2020
Main Category: Cancer / Oncology
Also Included In: Public Health
Article Date: 23 Feb 2009

"The investigators employed a human capital method as a means to calculate the expected lifetime earnings that would have been realized had the cancer or death been avoided. It assumes that earnings reflect underlying productivity, and does not measure the value of a life, only the value of labor."

"This study supports that the costs from premature cancer mortality are substantial. In 2007, the productivity costs from cancer deaths amounted to 1% of the US gross domestic product. Clearly lung cancer dominates the loss of productivity costs."

http://www.medilexicon.com/medicalnews.php?newsid=139911